James A S Muldowney

Author PubWeight™ 13.38^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	A pharmacogenetic versus a clinical algorithm for warfarin dosing.	N Engl J Med	2013	7.09
2	Thrombin modulates the expression of a set of genes including thrombospondin-1 in human microvascular endothelial cells.	J Biol Chem	2005	1.01
3	Plasminogen activator inhibitor-1 has a circadian rhythm in blind individuals.	Thromb Haemost	2007	0.83
4	Smallpox vaccination does not elevate systemic levels of prothrombotic proteins associated with ischemic cardiac events.	J Infect Dis	2005	0.81
5	The pharmacokinetics and pharmacodynamics of valsartan in the post-myocardial infarction population.	Expert Opin Drug Metab Toxicol	2012	0.77
6	Endogenous NO regulates plasminogen activator inhibitor-1 during angiotensin-converting enzyme inhibition.	Hypertension	2006	0.77
7	Microarray analysis of neointima: flowing toward a clear future.	Arterioscler Thromb Vasc Biol	2002	0.75
8	Combination therapy with clopidogrel and proton-pump inhibitors.	Lancet	2010	0.75
9	The Impact of Inpatient Versus Outpatient Initiation on Early Warfarin Dosing.	Am J Cardiovasc Drugs	2015	0.75
10	A very late stent thrombosis in a patient with diabetes: a call for lifelong dual anti-platelet therapy.	Tenn Med	2009	0.75